Bank of New York Mellon Corp grew its stake in Haleon plc (NYSE:HLN – Free Report) by 29.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,071,017 shares of the company’s stock after buying an additional 475,934 shares during the period. Bank of New York Mellon Corp’s holdings in Haleon were worth $19,758,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the stock. Farther Finance Advisors LLC grew its position in Haleon by 33.0% during the third quarter. Farther Finance Advisors LLC now owns 10,936 shares of the company’s stock worth $116,000 after buying an additional 2,715 shares in the last quarter. Axxcess Wealth Management LLC raised its stake in shares of Haleon by 2.3% in the 3rd quarter. Axxcess Wealth Management LLC now owns 63,843 shares of the company’s stock valued at $675,000 after buying an additional 1,450 shares in the last quarter. Crossmark Global Holdings Inc. increased its stake in Haleon by 55.6% in the third quarter. Crossmark Global Holdings Inc. now owns 480,760 shares of the company’s stock valued at $5,087,000 after acquiring an additional 171,877 shares during the period. Chartwell Investment Partners LLC boosted its holdings in Haleon by 107.8% during the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock valued at $5,030,000 after purchasing an additional 246,594 shares in the last quarter. Finally, WCM Investment Management LLC boosted its stake in Haleon by 36.6% in the 3rd quarter. WCM Investment Management LLC now owns 158,765 shares of the company’s stock valued at $1,694,000 after buying an additional 42,530 shares in the last quarter. 6.67% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
HLN has been the topic of several recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a report on Friday, January 10th. HSBC reissued a “hold” rating on shares of Haleon in a report on Wednesday, March 5th. Hsbc Global Res lowered shares of Haleon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 5th. Finally, Sanford C. Bernstein lowered Haleon from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 8th. Six investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $10.95.
Haleon Stock Down 0.7 %
HLN opened at $10.38 on Tuesday. Haleon plc has a fifty-two week low of $7.89 and a fifty-two week high of $10.80. The company has a market capitalization of $46.97 billion, a P/E ratio of 30.51, a P/E/G ratio of 2.82 and a beta of 0.25. The stock has a fifty day moving average of $9.68 and a 200-day moving average of $9.86. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84.
Haleon (NYSE:HLN – Get Free Report) last released its earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a return on equity of 14.76% and a net margin of 10.85%. The firm had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. On average, equities analysts expect that Haleon plc will post 0.43 EPS for the current year.
Haleon Increases Dividend
The company also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be issued a dividend of $0.1166 per share. This is an increase from Haleon’s previous — dividend of $0.05. The ex-dividend date of this dividend is Friday, April 25th. This represents a dividend yield of 1.6%. Haleon’s dividend payout ratio (DPR) is 58.97%.
About Haleon
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Further Reading
- Five stocks we like better than Haleon
- What is the S&P/TSX Index?
- How to Protect Your Portfolio When Inflation Is Rising
- What is a SEC Filing?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.